“…In studies comparing children with and without AD, few children with AD were sensitized to tixocortol pivalate ( n = 23) or budesonide ( n = 6), and the weighted average sensitization rates for the two markers did not differ significantly between the two groups (tixocortol pivalate 0·8%, n = 23 vs. 0·5%, n = 14; P = 0·16, budesonide 0·2%, n = 6 vs. 0·08%, n = 2; P = 0·24). In the eight studies on patients with AD only, three children were sensitized, all to tixocortol‐21‐pivalate …”